Type 1 insulin-like growth factor signalling in malignant melanoma
<p>Novel therapeutic strategies are sorely required for malignant melanoma, which has been shown to overexpress the type 1 insulin-like growth factor receptor (IGF1R) compared to benign naevi. The IGF1R mediates many features of the malignant phenotype and is an attractive anti-cancer therapeu...
| Autori principali: | , |
|---|---|
| Altri autori: | |
| Natura: | Tesi |
| Lingua: | English |
| Pubblicazione: |
2012
|
| Soggetti: |